Spruce Biosciences
Biotechnology ResearchCalifornia, United States11-50 Employees
Spruce Biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.
Insights
Innovative Therapeutics Spruce Biosciences is focused on developing novel therapies for rare endocrine and neurological disorders, indicating a strong need for specialized treatment solutions and potential partnerships in rare disease markets.
Strategic Collaborations Recent collaborations with Kaken Pharmaceutical for developing and commercializing tildacerfont in Japan highlight opportunities for expanding distribution channels and licensing deals in international markets.
Funding & Growth With over $50 million raised and ongoing clinical trials, Spruce Biosciences is in a growth phase, creating opportunities to offer sales solutions related to clinical research support and partner engagement.
Market Penetration The company's focus on late-stage clinical trials and recent topline results suggest a readiness for commercial partnerships and outreach to healthcare providers actively treating rare endocrine conditions.
Technology & Data Spruce's use of modern web technologies and strategic data-driven approaches indicates a receptive environment for innovative digital health solutions and patient management systems as part of the treatment ecosystem.
Similar companies to Spruce Biosciences
Calithera Biosciences
$25M$50MMyovant Sciences
$25M$50MZosano Pharma
$50M$100MAntios Therapeutics
$1M$10MCRISPR Therapeutics
$250M$500MSigilon, Inc.
$10M$25MPandion Therapeutics
$1M$10M
Spruce Biosciences Tech Stack
Spruce Biosciences uses 6 technology products and services including Akamai, Drupal, Modernizr, and more. Explore Spruce Biosciences's tech stack below.
- AkamaiContent Delivery Network
- DrupalContent Management System
- ModernizrJavascript Libraries
- Adobe Tag ManagerTag Management
- ZURB FoundationUI Frameworks
- Adobe FontsWeb Fonts
Media & News
Spruce Biosciences's Email Address Formats
Spruce Biosciences uses at least 1 format(s):
| Spruce Biosciences Email Formats | Percentage |
| FLast@sprucebiosciences.com | 81% |
| First@sprucebiosciences.com | 10% |
| Last@sprucebiosciences.com | 5% |
| First.Last@sprucebiosciences.com | 4% |
Frequently Asked Questions
Where is Spruce Biosciences's headquarters located?
Spruce Biosciences's main headquarters is located at 611 Gateway Boulevard South San Francisco, California 94080 United States. The company has employees across 1 continents, including North America. What is Spruce Biosciences's official website and social media links?
Spruce Biosciences's official website is sprucebiosciences.com and has social profiles on LinkedInCrunchbase.What is Spruce Biosciences's SIC code NAICS code?
Spruce Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Spruce Biosciences have currently?
As of February 2026, Spruce Biosciences has approximately 26 employees across 1 continents, including North America. Key team members include Vice President Pharmaceutical Development And Manufacturing: S. G.Vice President Development Operations: S. H.Head Of Patient Advocacy (fractional): R. S.. Explore Spruce Biosciences's employee directory with LeadIQ.What industry does Spruce Biosciences belong to?
Spruce Biosciences operates in the Biotechnology Research industry. What technology does Spruce Biosciences use?
Spruce Biosciences's tech stack includes AkamaiDrupalModernizrAdobe Tag ManagerZURB FoundationAdobe Fonts. What is Spruce Biosciences's email format?
Spruce Biosciences's email format typically follows the pattern of FLast@sprucebiosciences.com. Find more Spruce Biosciences email formats with LeadIQ. How much funding has Spruce Biosciences raised to date?
As of February 2026, Spruce Biosciences has raised $50M in funding. The last funding round occurred on Oct 08, 2025 for $50M.When was Spruce Biosciences founded?
Spruce Biosciences was founded in 2016.
Company Overview
- Headquarters
- 611 Gateway Boulevard South San Francisco, California 94080 United States
- Website
- sprucebiosciences.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2016
- Employees
- 11-50
Media & News
Funding & Financials
- $50M
Spruce Biosciences has raised a total of $50M of funding over 4 rounds. Their latest funding round was raised on Oct 08, 2025 in the amount of $50M.
- $10M$25M
Spruce Biosciences's revenue is estimated to be in the range of $10M$25M
Funding & Financials
- $50M
Spruce Biosciences has raised a total of $50M of funding over 4 rounds. Their latest funding round was raised on Oct 08, 2025 in the amount of $50M.
- $10M$25M
Spruce Biosciences's revenue is estimated to be in the range of $10M$25M
Company Leadership
S. G.Vice President Pharmaceutical Development And Manufacturing
S. H.Vice President Development Operations- R. S.Head Of Patient Advocacy (fractional)
- A. H.Founder
- M. G.Executive Chairman
Employee Directory
- S. H.Vice President Development Operations
T. C.Executive Director, Global Clinical Development- L. L.Associate Director Project Management
- M. V.Senior Director Patient Engagement & Advocacy
- Y. H.Principal
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
